Atp (Apple Tree Partners)

Atp (Apple Tree Partners) company information, Employees & Contact Information

Founded in 1999, ATP is a leader in life sciences venture capital.  ATP creates companies starting at various stages, from pre-IP ideas to asset spinouts, investing in them from seed stage through IPO and beyond.  The core of ATP’s strategy is to provide flexible capital and access to a world-class team of venture partners and EIRs, to build sustainable, research-driven enterprises that improve human lives.  For more information, visit www.appletreepartners.com.

Company Details

Employees
33
Founded
-
Address
230 Park Avenue,
Phone
212.468.5800
Email
in****@****ers.com
Industry
Venture Capital And Private Equity Principals
NAICS
Miscellaneous Intermediation
HQ
New York, New York
Looking for a particular Atp (Apple Tree Partners) employee's phone or email?

Atp (Apple Tree Partners) Questions

News

Biotechs caught in dispute between Apple Tree Partners , Rybolovlev - BioCentury

Biotechs caught in dispute between Apple Tree Partners , Rybolovlev BioCentury

Exclusive: Ascidian CEO Michael Ehlers leaves Apple Tree Partners for MPM BioImpact - Endpoints News

Exclusive: Ascidian CEO Michael Ehlers leaves Apple Tree Partners for MPM BioImpact Endpoints News

Apple Tree Partners Launches Red Queen Therapeutics to Bring Potentially Lifesaving Treatments to People at Greatest Risk from Viral Infections - PR Newswire

Apple Tree Partners Launches Red Queen Therapeutics to Bring Potentially Lifesaving Treatments to People at Greatest Risk from Viral Infections PR Newswire

Curia and Replicate Bioscience Enter Strategic Collaboration to Create Groundbreaking Development Platform for Self-Replicating RNA (srRNA) - Business Wire

Curia and Replicate Bioscience Enter Strategic Collaboration to Create Groundbreaking Development Platform for Self-Replicating RNA (srRNA) Business Wire

Small Fund, Big Dream: Apple Tree Partners - Venture Capital Journal

Small Fund, Big Dream: Apple Tree Partners Venture Capital Journal

Apple Tree Partners Unveils Deep Apple Therapeutics to Dramatically Accelerate Drug Discovery with Structure-Based, Ultra-Large Library Virtual Screening and Deep Learning Models - PR Newswire

Apple Tree Partners Unveils Deep Apple Therapeutics to Dramatically Accelerate Drug Discovery with Structure-Based, Ultra-Large Library Virtual Screening and Deep Learning Models PR Newswire

Nereid Therapeutics surfaces with $50M to go after biomolecular condensates - Fierce Biotech

Nereid Therapeutics surfaces with $50M to go after biomolecular condensates Fierce Biotech

With $75 Million from Apple Tree Partners, Initial Therapeutics Launches to Create a New Kind of Drug Designed to Stop the Formation of Difficult-to-Drug Protein Targets - PR Newswire

With $75 Million from Apple Tree Partners, Initial Therapeutics Launches to Create a New Kind of Drug Designed to Stop the Formation of Difficult-to-Drug Protein Targets PR Newswire

ATP and NYU Langone Health Launch Aethon Therapeutics to Eradicate Drug-Resistant Cancer Cells - PR Newswire

ATP and NYU Langone Health Launch Aethon Therapeutics to Eradicate Drug-Resistant Cancer Cells PR Newswire

ATP Announces $40 Million in Series A Funding for srRNA Therapeutics Trailblazer Replicate Bioscience - PR Newswire

ATP Announces $40 Million in Series A Funding for srRNA Therapeutics Trailblazer Replicate Bioscience PR Newswire

Marengo Therapeutics Launches with $80M from ATP, Appoints CEO Zhen Su, MD, to Deliver Breakthrough Cancer Treatments Using Its Selective T Cell Activation Repertoire (STAR) Platform - PR Newswire

Marengo Therapeutics Launches with $80M from ATP, Appoints CEO Zhen Su, MD, to Deliver Breakthrough Cancer Treatments Using Its Selective T Cell Activation Repertoire (STAR) Platform PR Newswire

Ascidian Therapeutics Launches to Rewrite RNA - PR Newswire

Ascidian Therapeutics Launches to Rewrite RNA PR Newswire

ATP Unveils Non-Viral Gene Therapy Innovator Intergalactic Therapeutics with $75 Million in Series A Funding - PR Newswire

ATP Unveils Non-Viral Gene Therapy Innovator Intergalactic Therapeutics with $75 Million in Series A Funding PR Newswire

Intergalactic Therapeutics Appoints Theresa G.H. Heah, M.D., M.B.A., as Chief Executive Officer - PR Newswire

Intergalactic Therapeutics Appoints Theresa G.H. Heah, M.D., M.B.A., as Chief Executive Officer PR Newswire

Nine Square Therapeutics Appoints Robert Paul as CEO - PR Newswire

Nine Square Therapeutics Appoints Robert Paul as CEO PR Newswire

Precision NanoSystems and Replicate Bioscience in licensing deal to scale up genomic medicines - PR Newswire

Precision NanoSystems and Replicate Bioscience in licensing deal to scale up genomic medicines PR Newswire

Corvidia Therapeutics Raises $26M in a Series A Financing, Led by Sofinnova Partners and Apple Tree Partners - PR Newswire

Corvidia Therapeutics Raises $26M in a Series A Financing, Led by Sofinnova Partners and Apple Tree Partners PR Newswire

Chinook Therapeutics Raises $65 Million Series A Financing to Advance Precision Medicines for Kidney Diseases - PR Newswire

Chinook Therapeutics Raises $65 Million Series A Financing to Advance Precision Medicines for Kidney Diseases PR Newswire

Akero Therapeutics Closes $65 Million Series A Financing to Advance New Treatments for Serious Metabolic Diseases - PR Newswire

Akero Therapeutics Closes $65 Million Series A Financing to Advance New Treatments for Serious Metabolic Diseases PR Newswire

Top Atp (Apple Tree Partners) Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant